• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Manufacturing & Development Services basecamp

    Basecamp
    Manufacturing & Development Services Overview

    Capabilities & Services
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D life edit

    Life Edit
    Gene Editing Technologies and R&D Overview

    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers

ElevateBio to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Cambridge, Mass., January 8, 2021 – ElevateBio, LLC, a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021 8:40 a.m. ET.  An audio-only webcast of the presentation will be available on January 13th on the Investors & Media section of the ElevateBio website at https://www.elevate.bio/investors-and-media. An archived replay of the presentation will be available for approximately 30 days following the presentation.

About ElevateBio
ElevateBio, LLC, is a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies. It begins with an environment where scientific inventors can transform their visions for cell and gene therapies into reality for patients with devastating and life-threatening diseases. Working with leading academic researchers, medical centers, and corporate partners, ElevateBio’s team of scientists, drug developers, and company builders are creating a portfolio of therapeutics companies that are changing the face of cell and gene therapy and regenerative medicine. Core to ElevateBio’s vision is BaseCamp, a centralized state-of-the-art innovation and manufacturing center, providing fully integrated capabilities, including basic and transitional research, process development, clinical development, cGMP manufacturing, and regulatory affairs across multiple cell and gene therapy and regenerative medicine technology platforms. ElevateBio portfolio companies, as well as select strategic partners are supported by ElevateBio BaseCamp in the advancement of novel cell and gene therapies.

ElevateBio’s investors include F2 Ventures, MPM Capital, EcoR1 Capital, Redmile Group, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, and Vertex Ventures.

ElevateBio is headquartered in Cambridge, Mass, with ElevateBio BaseCamp located in Waltham, Mass. For more information, please visit www.elevate.bio.

Media Contact:
‍
Courtney Heath
ScientPR
[email protected]‍
617-872-2462
‍

ElevateBio Investor contact:
‍Medha Chadha
[email protected]

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Development Services basecamp
  • Gene Editing Technologies and R&D life edit
  • Genetic Medicines
  • Partnering
  • About
  • Posters & Publications
  • Elevated Insights
  • Careers
  • Locations
  • Contact
MENU
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact